Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 1/2006

01-02-2006 | Short Report

X-linked creatine transporter defect: A report on two unrelated boys with a severe clinical phenotype

Authors: I. M. Anselm, F. S. Alkuraya, G. S. Salomons, C. Jakobs, A. B. Fulton, M. Mazumdar, M. Rivkin, R. Frye, T. Young Poussaint, D. Marsden

Published in: Journal of Inherited Metabolic Disease | Issue 1/2006

Login to get access
Metadata
Title
X-linked creatine transporter defect: A report on two unrelated boys with a severe clinical phenotype
Authors
I. M. Anselm
F. S. Alkuraya
G. S. Salomons
C. Jakobs
A. B. Fulton
M. Mazumdar
M. Rivkin
R. Frye
T. Young Poussaint
D. Marsden
Publication date
01-02-2006
Publisher
Kluwer Academic Publishers
Published in
Journal of Inherited Metabolic Disease / Issue 1/2006
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-006-0123-4

Other articles of this Issue 1/2006

Journal of Inherited Metabolic Disease 1/2006 Go to the issue

Observations and Opinions

Notes and Queries in Metab-L

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine